Tag: drugmaker-said
-
Valeant gets additional notices of default from bondholders
The notices do not accelerate its indebtedness, the company said. The Quebec-based drugmaker said last week it had received a notice of default from its bondholders. The company has since received an extra month from its lenders to file the annual report.
-
Valeant gets additional notices of default from bondholders
The notices do not accelerate its indebtedness, the company said. The Quebec-based drugmaker said last week it had received a notice of default from its bondholders. The company has since received an extra month from its lenders to file the annual report.
-
U.S. probes toy jewelry kits linked to high lead levels
Elliot Kaye, who chairs the U.S. Consumer Product Safety Commission, said on Friday that he is examining the safety of Cra-Z-Art kits after New York Attorney General Eric Schneiderman called on several big retailers to pull them from store shelves. A similar demand was made to LaRose Industries LLC, a Randolph, New Jersey-based company that…
-
U.S. probes toy jewelry kits linked to high lead levels
Elliot Kaye, who chairs the U.S. Consumer Product Safety Commission, said on Friday that he is examining the safety of Cra-Z-Art kits after New York Attorney General Eric Schneiderman called on several big retailers to pull them from store shelves. A similar demand was made to LaRose Industries LLC, a Randolph, New Jersey-based company that…
-
U.S. judge allows CIA interrogation lawsuit to proceed
A U.S. judge on Friday refused to dismiss a lawsuit against the former military psychologists who developed the CIA's interrogation program during George W. Bush's presidency, handing a major victory to a group of men who said they were tortured in secret prisons abroad. U.S. District Court Judge Justin Quackenbush's decision to allow the case…
-
Novartis trial shows drug improves survival for AML patients
ZURICH (Reuters) – Novartis' phase III study for its acute myeloid leukemia (AML) drug showed it improved overall survival by 23 percent for patients with FLT3 mutations, the Swiss drugmaker said on Sunday. Basel-based Novartis said the study was the first large controlled trial to show overall survival benefit in FLT3-mutated AML, and that worldwide…
-
VW denies Qatar talks sought to curb labor role
Volkswagen has denied a report saying its chief executive and chairman were urged on Sunday by its third-largest shareholder to reduce the influence of VW's powerful unions as it battles to overcome its emissions scandal. CEO Matthias Mueller and Chairman Hans Dieter Poetsch met with leaders of the Qatar Investment Authority (QIA) in Doha on…